IL79291A - Gram-positive expression control sequences of the bacillus subtilis bacteria - Google Patents

Gram-positive expression control sequences of the bacillus subtilis bacteria

Info

Publication number
IL79291A
IL79291A IL79291A IL7929186A IL79291A IL 79291 A IL79291 A IL 79291A IL 79291 A IL79291 A IL 79291A IL 7929186 A IL7929186 A IL 7929186A IL 79291 A IL79291 A IL 79291A
Authority
IL
Israel
Prior art keywords
gram
expression control
positive expression
positive
bacillus subtilis
Prior art date
Application number
IL79291A
Other languages
English (en)
Other versions
IL79291A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL79291A0 publication Critical patent/IL79291A0/xx
Publication of IL79291A publication Critical patent/IL79291A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL79291A 1985-07-05 1986-06-30 Gram-positive expression control sequences of the bacillus subtilis bacteria IL79291A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858517071A GB8517071D0 (en) 1985-07-05 1985-07-05 Gram-positive expression control sequence

Publications (2)

Publication Number Publication Date
IL79291A0 IL79291A0 (en) 1986-09-30
IL79291A true IL79291A (en) 1991-06-30

Family

ID=10581857

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79291A IL79291A (en) 1985-07-05 1986-06-30 Gram-positive expression control sequences of the bacillus subtilis bacteria

Country Status (12)

Country Link
US (1) US4868111A (da)
EP (1) EP0207459B1 (da)
JP (2) JP2632809B2 (da)
AT (1) ATE62020T1 (da)
AU (1) AU594349B2 (da)
CA (1) CA1316850C (da)
DE (1) DE3678343D1 (da)
DK (1) DK175206B1 (da)
GB (1) GB8517071D0 (da)
IE (1) IE59165B1 (da)
IL (1) IL79291A (da)
NZ (1) NZ216688A (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266474A (en) * 1987-06-24 1993-11-30 Genentech, Inc. Balanced inducible transcription system
EP0303925B1 (de) * 1987-08-17 1995-06-07 F. Hoffmann-La Roche Ag Hochreprimierbare Expressionskontrollsequenzen
US5726042A (en) * 1988-04-07 1998-03-10 Abbott Laboratories Expression of heterologous proteins in Bacillus megaterium utilizing sporulation promoters of Bacillus subtilis
GB8811761D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Biosynthetic process for preparation of chemical compounds
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
FR2679568B1 (fr) * 1991-07-22 1994-09-02 Pasteur Institut Nouveau type de replicon gram-positif - construction de vecteurs recombinants le contenant.
GB2278358B (en) 1992-02-27 1995-07-26 Lynxvale Ltd Heterologous gene expression in Lactococcus,and the expression products therefrom
US6022730A (en) * 1994-06-17 2000-02-08 Robinson; Douglas H. Methods for the isolation of bacteria containing eukaryotic genes
US5629205A (en) * 1995-05-19 1997-05-13 Allelix Biopharmaceuticals Inc. Promoters for gene expression
US6194168B1 (en) * 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
US6146848A (en) * 1998-07-23 2000-11-14 The Hong Kong University Of Science & Technology Bacterial expression system
US6720174B1 (en) 1999-01-28 2004-04-13 Novozymes A/S Phytases
EP2502998A3 (en) * 1999-04-09 2013-02-27 Intercell USA, Inc. Recombinant toxin A/ToxinB vaccine against clostridium difficile
DE60142609D1 (de) * 2000-10-25 2010-09-02 Fujifilm Corp Methode zur Analyse doppelsträngiger DNA
AU2002365223A1 (en) * 2001-10-26 2003-09-02 Id Biomedical Corporation Of Washington Multivalent streptococcal vaccine compositions and methods for use
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2005052151A1 (en) 2003-11-19 2005-06-09 Dow Global Technologies Inc. Improved protein expression systems
MXPA06005705A (es) 2003-11-21 2006-08-23 Dow Global Technologies Inc Sistemas de expresion mejorada con secrecion de sistema de sec.
ES2707786T3 (es) 2004-01-16 2019-04-05 Pfenex Inc Expresión de proteínas de mamífero en Pseudomonas fluorescens
AU2005269527B2 (en) 2004-07-26 2011-12-01 Pfenex Inc. Process for improved protein expression by strain engineering
GB0602173D0 (en) * 2006-02-03 2006-03-15 Avecia Ltd Expression system
AU2007311444B2 (en) * 2006-10-18 2012-11-29 Periness Ltd. Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
CN102517280A (zh) 2007-01-31 2012-06-27 菲尼克斯股份有限公司 用于提高表达的细菌前导序列
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
AU2010247938B2 (en) 2009-05-11 2016-02-18 Pelican Technology Holdings, Inc. Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
ES2639398T3 (es) 2010-03-04 2017-10-26 Pfenex Inc. Método para producir proteína de interferón recombinante soluble sin desnaturalización
NZ602958A (en) 2010-03-30 2014-07-25 Pfenex Inc High level expression of recombinant toxin proteins
US8455218B2 (en) 2010-04-01 2013-06-04 Pfenex, Inc. Methods for G-CSF production in a Pseudomonas host cell
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2016073079A2 (en) 2014-09-26 2016-05-12 Yale University Compositions and methods for biocontainment of microorganisms
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク. ペプチド産生のための融合パートナー
AU2018354067B2 (en) 2017-10-27 2023-03-30 Pfenex Inc. Method for production of recombinant Erwinia asparaginase
KR20200073280A (ko) 2017-10-27 2020-06-23 피페넥스 인크. 주변세포질 단백질 발현을 위한 박테리아 리더 서열
US11149280B2 (en) 2019-10-29 2021-10-19 Yale University Engineering organisms resistant to viruses and horizontally transferred genetic elements
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
WO2023178316A2 (en) 2022-03-17 2023-09-21 Yale University Compositions and methods for expressing synthetic genetic elements across diverse microorganisms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495280A (en) * 1981-05-20 1985-01-22 The Board Of Trustees Of The Leland Stanford Jr. University Cloned high signal strength promoters
GR81701B (da) 1983-01-18 1984-12-12 Lilly Co Eli
EP0115936A1 (en) * 1983-01-24 1984-08-15 Kabushiki Kaisha Yakult Honsha Chimeric plasmids

Also Published As

Publication number Publication date
DK320686A (da) 1987-01-06
GB8517071D0 (en) 1985-08-14
IE59165B1 (en) 1994-01-12
IE861806L (en) 1987-01-05
EP0207459A3 (en) 1988-07-06
JPS6214786A (ja) 1987-01-23
JP2887248B2 (ja) 1999-04-26
EP0207459A2 (en) 1987-01-07
IL79291A0 (en) 1986-09-30
AU594349B2 (en) 1990-03-08
ATE62020T1 (de) 1991-04-15
NZ216688A (en) 1990-06-26
DK175206B1 (da) 2004-07-12
DK320686D0 (da) 1986-07-04
JP2632809B2 (ja) 1997-07-23
EP0207459B1 (en) 1991-03-27
CA1316850C (en) 1993-04-27
JPH10229878A (ja) 1998-09-02
US4868111A (en) 1989-09-19
AU5938586A (en) 1987-01-08
DE3678343D1 (de) 1991-05-02

Similar Documents

Publication Publication Date Title
IL79291A (en) Gram-positive expression control sequences of the bacillus subtilis bacteria
EP0048970A3 (en) Polypeptides, process for their microbial production, intermediates therefor and compositions containing them
CA2153068A1 (en) Enhancer sequence for modulating expression in epithelial cells
ZA926705B (en) Dna sequences encoding gelonin polypeptides
DE3686579D1 (en) Prokaryotisches expressionssystem.
GR851866B (da)
AU592791B2 (en) Recombinant DNA expression vectors and DNA compounds which encode isopenicillin N synthetase
DE3666838D1 (en) Plasmid vectors for expression in escherichia coli and/or bacillus subtilis
DK509886D0 (da) Udtrykkelsesforoegende dna-sekvenser
AU591477B2 (en) Molecular cloning of the -endotoxin gene of bacillus thuringiensis var. israelensis
AU589151B2 (en) New expression control sequence
AU1099697A (en) Novel xylanases, genes encoding them, and uses thereof
TW342413B (en) Novel toxins isolated from Bracon Hebetor
AU4568496A (en) Acarbose biosynthesis genes from Actinoplanes sp., process for the isolation thereof and the use thereof
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
KR910000180A (ko) 트롬빈 억제 활성을 갖는 폴리펩티드 및 그의 제조방법
AU7718294A (en) Mammalian stromal cell proteins and dna sequences coding therefor

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired